DSCAM/PAK1 pathway suppression reverses neurogenesis deficits in iPSC-derived cerebral organoids from patients with Down syndrome. Tang XY, Xu L, Wang J, Hong Y, et al. J Clin Invest 2021;131.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tang XY, Xu L, Wang J, Hong Y, et al. DSCAM/PAK1 pathway suppression reverses neurogenesis deficits in iPSC-derived cerebral organoids from patients with Down syndrome. J Clin Invest 2021;131.
PMID: 33945512